CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-3190
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2015
Authors
Publisher
American Association for Cancer Research (AACR)